UMYU Scientifica

A periodical of the Faculty of Natural and Applied Sciences, UMYU, Katsina

ISSN: 2955 – 1145 (print); 2955 – 1153 (online)

ORIGINAL RESEARCH ARTICLE

Probiotics As Alternatives to Antibiotics in Poultry: A Comprehensive Review of Mechanisms and Impacts on Antimicrobial Resistance (2021–2025)

Amina Muhammad Darma, Kamaluddeen Kabir, Bashir Abdulkadir, and Yusuf Munir Aliyu

Department of Microbiology, Umaru Musa Yar’adua University, PMB 2218, Katsina, Nigeria

Corresponding author: Amina Muhammad Darma aminadarma3436@gmail.com

Abstract

The recent ban on the use of antibiotic growth promoters in poultry production worldwide, prompted by increased antimicrobial resistance, has hindered the pursuit of sustainable sources. Probiotics have emerged as promising alternatives, but a synthesis of recent high-quality evidence is needed to guide policy and practical application. A literature search was conducted across major databases (PubMed/MEDLINE, Scopus, Web of Science, Google Scholar), retrieving 2,808 peer-reviewed publications from 2021 to 2025. It was evident that probiotic supplementation significantly improved growth performance and feed efficiency, as well as increased intestinal villus height, enhanced barrier integrity, and modulated intestinal immune systems. Multi-strain and synbiotic preparations proved to be more effective than single-strain formulations. Notably, several studies indicated inhibition of antibiotic resistance gene expression and a lower prevalence of multidrug-resistant pathogens. Variability was observed due to probiotic strain, dosage, production system, and environmental factors. Probiotics represent viable alternatives to antibiotic growth promoters in poultry, offering benefits for productivity, gut health, and antimicrobial resistance reduction. Optimising formulation strategies, refining manufacturing processes, and establishing synchronised regulatory frameworks are vital for large-scale implementation. Probiotic-based interventions could serve as a long-term solution to achieving antibiotic-free poultry production and improving food safety globally. Future research should focus on elucidating probiotic mechanisms of action through multi-omics techniques. Additionally, developing computational models for personalised probiotic selection, conducting longitudinal studies to assess long-term effects, and standardising international regulatory approaches to define and validate probiotic characteristics are essential.

Keywords: Probiotic, Antimicrobial-Resistance, Gut microbiota, Poultry Feed.

INTRODUCTION

As one of the most rapidly expanding agricultural industries in the world, where more than 90 billion chickens are produced annually, the poultry industry has long been relying on antimicrobial growth promoters (AGPs) and therapeutic antibiotics to maximise productivity and control enteric diseases (Sharma et al., 2024). Nevertheless, this has changed dramatically in response to the growing menace of antimicrobial resistance (AMR). The excessive use and misapplication of antibiotics in commercial poultry production, especially at sub-therapeutic levels in growth promotion, have triggered similar crises in the animal and human health industries and have resulted in the rapid development and spread of multidrug-resistant bacteria (Ijaz et al., 2024; Sardar et al., 2024). Regulatory constraints, first by the European Union in 2006 (which banned AGPs) and then by many other countries, have responded to this, prompting a frantic search to find sustainable alternatives. Among the most effective approaches that can be used to replace antibiotics and retain or even increase the efficiency of poultry production is the use of probiotics, which refer to live and non-pathogenic microorganisms that allow offering health benefits to the host when used in sufficient amounts (Rauf et al., 2024; Nechitailo et al., 2024).

The review summarises previous studies (2021-2025) on probiotics as an alternative to antibiotics in poultry, with a focus on the quantitative data of performance, mechanism of action, and effects of mitigating antimicrobial resistance. As opposed to traditional literature reviews, which are usually descriptive of the trends in the past, in this analysis, the recent empirical evidence, effect sizes, and actionable implications towards sustainable production of poultry are placed in a central position.

METHODOLOGY

2.1 Study Design

This review was conducted in accordance with PRISMA guidelines as reported by Munir et al. (2025). It summarises the current research on probiotics from 2021 to 2025, which assesses the probiotics as a substitute for growth promoters used in the poultry industry to prevent antibiotic-resistant growth, focusing on growth performance, intestinal wellbeing, immune regulation, and reduction in antimicrobial resistance.

2.2 Eligibility Criteria

Eligible studies included randomised controlled trials and quasi-experimental poultry studies with control groups assessing defined probiotic, postbiotic interventions. Broilers, layers, and other domesticated poultry were included. Studies were required to report quantitative data on growth performance, gut health, antimicrobial resistance markers, and immune responses. Non-controlled, in vitro-only, non-poultry, and poorly described interventions were excluded.

2.3 Search Strategy and Information Sources.

The search was carried out across 5 databases (PubMed/MEDLINE, Scopus, Web of Science, Google Scholar) using search strings/Keywoards (probiotic OR "direct-fed microbe " OR DFM OR "live microorganism " OR "lactic acid bacteria" OR Lactobacillus OR Bifidobacterium OR Bacillus OR "Saccharomyces cerevisiae" OR postbiotic OR "fermentation product " OR synbiotic ) AND (poultry OR chicken OR broiler OR "laying hen " OR layer OR turkey OR duck OR "gallus gallus" OR avian) AND (antibiotic OR "antimicrobial resistance" OR AMR OR "growth promoter " OR "performance" OR microbiome OR "gut health" OR "intestinal health" OR "feed conversion") AND (2021:2025[Publication Date]). Only peer-reviewed articles published in the English language and published between 2021 and 2025 were searched. Reference checking and citation following were also done so that the study could be fully identified.

2.4 Study Selection

Two independent reviewers screened retrieved records in two steps (title/abstract and full text). The exclusion criteria were pre-established, and inconsistencies in inclusion cases were settled by consensus of a third-party arbitrator. The PRISMA flow diagram was used to record the process of selection (Figure 1).

2.5 Data Extraction

Two independent reviewers did the data extraction with the assistance of a standardised and pilot-tested form. The variables that were extracted were the study characteristics, poultry population information, probiotic formulation and dosage, comparator type and quantitative outcome data (means, standard deviations, sample sizes). One set of records was compared with another to achieve validity and reliability.

Figure 1: PRISMA flowchart illustrating the identification and selection of publications used in the study.

RESULT

Mechanisms of Action: How Probiotics Modulate Poultry Health

Probiotics exert their beneficial effects through multiple, interconnected mechanisms operating at the intestinal, microbial, and systemic levels. Understanding these mechanisms is essential for optimising strain selection and application strategies. The major probiotic strains and their mechanisms of action are summarised in Table 1.

Table 1. Mechanisms and Functional Effects of Probiotic Strains Commonly Used in Poultry

3.1 Competitive Exclusion and Microbial Balance

The foundational mechanism by which probiotics enhance poultry health is competitive exclusion of pathogenic microorganisms. Beneficial bacteria, particularly species of Lactobacillus, Bacillus, and Bifidobacterium, compete with pathogenic species for intestinal colonisation sites, nutrient substrates, and adhesion receptors (Halder et al., 2024). Studies employing 16S rRNA gene sequencing have demonstrated that probiotic supplementation significantly reduces the abundance of harmful bacteria, including Escherichia coli, Salmonella sp., and Clostridium perfringens. Notably, Sardar et al. (2024) reported that multi-strain probiotic supplementation at 500 mg/kg reduced pathogenic bacterial loads while simultaneously increasing beneficial Lactobacillus populations (Sardar et al., 2024).

3.2 Antimicrobial Compound Production

Probiotics generate multiple antimicrobial substances, including bacteriocins, organic acids (lactic acid, acetic acid, formic acid), hydrogen peroxide, and short-chain fatty acids (SCFAs), all of which directly inhibit pathogenic colonisation (Nechitailo et al., 2024). The production of butyrate, propionate, and acetate by probiotic fermentation not only reduces intestinal pH, creating an unfavourable environment for acid-sensitive pathogens, but also serves as the primary energy source for colonocytes, enhancing barrier integrity (Wang et al., 2024).

3.3 Intestinal Barrier Fortification and Morphological Enhancement

A critically important mechanism involves strengthening of the intestinal epithelial barrier. Probiotics enhance the expression of tight junction proteins, including claudin-1, occludin, and zonula occludens-1 (ZO-1), thereby reducing paracellular transport of bacterial antigens and endotoxins (Naeem & Bourassa, 2025). This effect is accompanied by measurable improvements in intestinal histomorphology: Wang et al. (2024) demonstrated that compound probiotics composed of Enterococcus faecium, Bifidobacterium, and Pediococcus acidilactici significantly increased duodenal and jejunal villi height and reduced crypt depth, associated with elevated digestive enzyme activity and improved nutrient absorption (Wang et al., 2024).

3 .4 Immune Modulation and Cytokine Regulation

Probiotics stimulate both humoral and cell-mediated immune responses through toll-like receptor (TLR) signalling and systemic cytokine modulation. These microorganisms promote production of anti-inflammatory cytokines (IL-10, transforming growth factor-beta [TGF-β]) while simultaneously reducing pro-inflammatory markers (IL-6, TNF-α, IL-17) (Salahi & El-Ghany, 2024). Additionally, probiotic supplementation increases antibody titers against common poultry pathogens and enhances phagocytic activity and lymphocyte proliferation (Halder et al., 2024). The principal mechanistic pathways and supporting evidence are summarised in Table 2.

Table 2: Mechanistic Pathways of Probiotic Action in Poultry and Associated Microbial Components

3.5 Enhanced Nutrient Utilisation and Digestive Enzyme Activity

Probiotics produce a range of digestive enzymes, including proteases, amylases, and lipases, which enhance the breakdown and absorption of feed components (Sharma et al., 2024). This enzymatic contribution directly translates to improved feed conversion efficiency and nutrient bioavailability. Yoghurt fermented with Lactobacillus acidophilus and Streptococcus thermophilus significantly increased ileal digestibility of dry matter (DM), organic matter (OM), and crude protein (CP) in broilers (Hossain et al., 2025).

Quantitative Evidence: Growth Performance and Production Outcomes

Recent empirical studies provide robust quantitative evidence supporting the efficacy of probiotics as antibiotic replacements. This section synthesises performance metrics from recent studies and presents standardised effect sizes. Comparative growth performance outcomes are presented in Table 3.

Table 3. Summary of Probiotic Strains, Dosages, and Their Effects on Growth Performance in Poultry

4.1 Body Weight Gain (BWG) and Overall Growth Performance

Probiotic supplementation consistently improves body weight gain across broiler populations. A synthesis of recent data indicates mean improvements in body weight gain compared to unsupplemented controls (Rauf et al., 2024). Notably, synbiotic formulations (combining prebiotics and probiotics) demonstrate superior performance: Rauf et al. (2024) reported that the synbiotic group (0.1% inulin + 0.1% Lactobacillus/Bifidobacterium mix) exhibited the highest body weight gain, significantly outperforming prebiotic-only and probiotic-only groups

4.2 Feed Conversion Ratio (FCR): The Critical Efficiency Metric

Feed conversion ratio (FCR) improvements represent perhaps the most economically significant outcome for poultry producers. Probiotic supplementation yields measurable FCR improvements, with the most substantial improvements observed in early production phases. Hossain et al. (2025) reported improvements in broilers receiving yoghurt co-fermented with L. acidophilus and S. thermophilus during the 0–14-day period, with effects persisting through the growing and finishing phases

4.3 Carcass Characteristics and Meat Quality

Beyond growth metrics, probiotics enhance carcass yield and meat quality attributes. Dressing percentages increase, with probiotic-supplemented birds exhibiting improved breast yield and reduced abdominal fat deposition. Sardar et al. (2024) demonstrated that multi-strain probiotic-fed broilers (500 mg/kg) had significantly improved meat quality, including enhanced antioxidant properties, higher protein and fibre content, and lower fat and ash levels compared to both antibiotic-treated and control groups

4.4 Mortality Reduction and Health Metrics

Probiotic supplementation reduces overall mortality rates relative to unsupplemented controls (Naeem & Bourassa, 2025). Blood biochemical parameters improve systematically: serum total cholesterol, triglycerides, and low-density lipoprotein (LDL) concentrations decrease significantly, while high-density lipoprotein (HDL) and serum protein levels increase (Salahi & El-Ghany, 2024). These improvements suggest enhanced metabolic efficiency and reduced systemic inflammation. A consolidated quantitative summary of recent findings (2023–2024) is provided in Table 4.

Table 4: Quantitative Summary of Probiotic Effects on Broiler Performance (2023–2024)

Intestinal Health, Microbiota Composition, and Morphological Improvements

The gut microbiome serves as a critical interface between diet, host immunity, and disease resistance. Probiotics fundamentally reshape this ecosystem through both quantitative and qualitative changes.

5.1 Pathogenic Bacteria Suppression

Probiotic supplementation reduces populations of key intestinal pathogens with remarkable consistency across multiple studies. Mean reductions for pathogenic bacteria are documented across studies, with specific pathogens responding variably (Sardar et al., 2024), (Salahi & El-Ghany, 2024). These reductions directly address the zoonotic transmission route whereby resistant bacteria from poultry products contaminate the human food chain.

5.2 Beneficial Microbiota Enrichment

Concurrent with pathogenic suppression, probiotic supplementation dramatically increases beneficial bacterial populations. Lactobacillus abundance increases substantially, while Bifidobacterium populations expand significantly (Wang et al., 2024). These microorganisms produce the majority of intestinal short-chain fatty acids (SCFAs), with butyrate and propionate increasing significantly in supplemented birds

5.3 Intestinal Morphological Improvements

Quantitative histomorphological assessment reveals consistent enhancements. Wang et al. (2024) documented that compound probiotic supplementation increased duodenal and jejunal villi height, improved the V/C ratio, and reduced crypt depth compared to controls and antibiotic-treated groups (Wang et al., 2024). These morphological changes directly correlate with improved nutrient absorption capacity and enhanced intestinal barrier function.

5.4 Microbiota Diversity and Resilience

Alpha diversity indices respond variably to probiotic supplementation depending on strain composition and dosage (Lim et al., 2024). However, qualitative community structure improvements characterised by reduced abundance of pathogenic Clostridiales and enhanced beneficial Firmicutes are consistent (Nechitailo et al., 2024). This functional restructuring enhances resilience to pathogenic challenges and environmental stressors.

Translational Implications: From Poultry to Preterm Infant Health

The mechanisms by which probiotics enhance gut health and reduce pathogenic colonization in poultry have direct translational relevance to human medicine, particularly in the management of vulnerable preterm infant populations. Preterm infants, like poultry raised in intensive production systems, experience significant disruptions in gut microbiome development characterized by reduced microbial diversity, delayed colonization by beneficial commensals, and increased susceptibility to pathogen domination (Abdulkadir et al., 2020). These alterations contribute to a heightened risk of life-threatening conditions including necrotizing enterocolitis (NEC) and late-onset sepsis (LOS), which remain major causes of morbidity and mortality in neonatal intensive care units worldwide (Abdulkadir et al., 2016).

The parallels between poultry and preterm infant gut dysbiosis are striking. In both populations, factors such as antibiotic exposure, hospitalization in controlled environments (NICUs or poultry houses), and disruptions to vertical transmission of maternal microbiota fundamentally alter microbial succession patterns (Abdulkadir et al., 2020). Preterm infants, like broiler chickens, often develop simple gut microbiomes dominated by potentially pathogenic species including Klebsiella pneumoniae, Enterococcus faecalis, and Escherichia coli, while beneficial genera such as Bifidobacterium and Lactobacillus are significantly depleted (Abdulkadir et al., 2016). This dysbiotic state creates opportunities for bacterial translocation across the intestinal epithelium, leading to systemic infection and sepsis.

The impact of gut microbial diversity in preterm infant infections (Abdulkadir et al., 2020) comprehensively highlights how disruptions in early-life microbial colonization create vulnerability to invasive pathogens, a theme that directly parallels the competitive exclusion mechanisms discussed in Section 3.1 of this review. The paper emphasizes that certain factors including mode of delivery, socioeconomic and geographic factors, and gut microbial diversity itself are critical determinants of preterm infections, with NEC and sepsis representing the most crucial infections causing morbidity and mortality among preterm infants (Abdulkadir et al., 2020). In both poultry and preterm infants, reduced colonization resistance allows environmental pathogens to establish intestinal dominance, increasing infection risk.

The maternal factors contributing to these outcomes are particularly relevant in resource-limited settings. The effect of microbial infections in maternal premature delivery: an african context (Abdulkadir et al., 2016) addresses how maternal health status significantly influences birth outcomes and neonatal susceptibility to infection. The paper reports that over 60% of preterm births occur in Africa and South Asia, with countries including Nigeria, Democratic Republic of Congo, and others showing high prevalence rates (Abdulkadir et al., 2016).

Given these shared vulnerabilities, probiotics have emerged as a promising intervention in both poultry production and neonatal medicine. The impact of probiotics as dietary supplementation in the management of neonatal sepsis: a review (Abdulkadir et al., 2018) examines the evidence for probiotic-mediated protection against neonatal sepsis, a topic with direct mechanistic parallels to the antimicrobial resistance mitigation strategies discussed in Section 6 of this review. The paper notes that neonatal sepsis is responsible for approximately 30-50% of total neonatal deaths in developing countries, with up to 20% of neonates developing sepsis and approximately 1% dying from sepsis-related causes (Abdulkadir et al., 2018).

The mechanisms underlying probiotic-mediated protection in preterm infants are remarkably similar to those documented in poultry. As detailed in the impact of antibiotics and probiotics in the treatment of gastrointestinal tract infection (Abdulkadir et al., 2015) , probiotics enhance intestinal barrier function, produce antimicrobial substances including bacteriocins and organic acids, compete with pathogens for colonization sites, and modulate immune responses (Abdulkadir et al., 2016). The paper explains that probiotic bacteria, predominantly Lactobacillus and Bifidobacterium species, are able to decrease the duration of diarrhea, reduce allergic syndromes, deliver various bacteriocins, and lower the pH, subsequently inhibiting invasion of pathogens such as Salmonella spp. and Escherichia coli (Abdulkadir et al., 2016). These mechanisms directly parallel the pathogen suppression and beneficial microbiota enrichment documented in poultry studies (Table 5).

Regarding safety, the impact of probiotics as dietary supplementation in the management of neonatal sepsis: a review confirms that specific strains of probiotics are safe for infant use and able to confer health benefits, though bacterial sepsis related to probiotic use in children and infants has occasionally been reported, including cases of Lactobacillus bacteremia in premature infants with short gut syndrome and LGG endocarditis (Abdulkadir et al., 2018). However, the paper concludes that the application of probiotics to prevent and treat neonatal sepsis should be more widely considered by the medical community, with good evidence supporting their safety and efficacy (Adulkadir et al., 2018).

The convergence of evidence across poultry and human neonatal applications underscores the broader relevance of probiotic-based strategies for managing antimicrobial resistance. By reducing reliance on therapeutic antibiotics in both agricultural and clinical settings, probiotics address the growing threat of antimicrobial resistance at its source. As outlined in Section 6.3, probiotics do not select for cross-resistance or promote collateral resistance development, offering a sustainable alternative to conventional antimicrobial interventions. The integration of findings from poultry science with human neonatal research exemplified by these studies demonstrates the "One Health" approach essential for addressing the complex challenge of antimicrobial resistance in the 21st century.

Antimicrobial Resistance Mitigation: A Critical Public Health Outcome

The emergence and dissemination of antibiotic-resistant bacteria represents one of the most pressing global health threats, with poultry production identified as a major reservoir and transmission vector (Ijaz et al., 2024). Probiotics address this crisis through multiple pathways. Key antimicrobial resistance mitigation outcomes are summarised in Table 5.

7.1 Reduction of Antibiotic Resistance Gene Expression

Probiotic supplementation suppresses the expression of antibiotic resistance genes (ARGs) compared to antibiotic-treated controls (Muneeb et al., 2024). This reduction is mechanistically linked to the compositional shift toward low-antibiotic-resistance-burden microbiota and competitive suppression of resistant bacterial lineages.

7.2 Reduced Prevalence of Multidrug-Resistant Pathogens

Probiotic-supplemented broilers exhibit substantially lower prevalence of multidrug-resistant E. coli and Salmonella strains (Sardar et al., 2024). These results directly address the zoonotic transmission route whereby resistant bacteria from poultry products contaminate the human food chain.

7.3 Prevention of Cross-Resistance Development

A particularly important finding is that probiotics do not select for cross-resistance or promote collateral resistance development, concerns that plague antibiotic alternatives. Multiple studies confirm that probiotic supplementation does not elevate resistance to non-antibiotic antimicrobial compounds or create novel resistance phenotypes (Rahman et al., 2022).

7.4 Impact on Poultry-Associated Human Pathogens

Evidence increasingly demonstrates that probiotics reduce the risk of transmission of poultry-origin resistant bacteria to humans. By suppressing pathogenic bacteria shedding and reducing intestinal carriage of multidrug-resistant strains, probiotics diminish contamination of meat and visceral organs (Ruvalcaba-Gomez et al., 2022).

Table 5: Antimicrobial Resistance Mitigation by Probiotics

Comparative Efficacy: Probiotics Versus Therapeutic Antibiotics

8.1 Growth Performance Parity

Direct comparative studies reveal that probiotics achieve growth performance outcomes comparable to or exceeding those of therapeutic antibiotics when used at sub-inhibitory/growth-promotional doses (Rauf et al., 2024). Notably, probiotic-treated birds showed improved small intestinal morphology compared to antibiotic-treated birds, despite equivalent or superior growth metrics (Argaaraz-Martinez et al., 2024). As illustrated in Figure 2, probiotics offer a potential alternative to antibiotics.

8.2 Immune Function Enhancement

A critical distinction emerges when comparing immune outcomes. While therapeutic antibiotics suppress pro-inflammatory responses through broad-spectrum killing of intestinal microbiota, this creates immunosuppressive effects (Gunawardana et al., 2022). Conversely, probiotics enhance both innate and adaptive immune responses.

8.3 Sustainability and Reversibility

A crucial advantage of probiotics is their reversibility and sustainability. Discontinuation of antibiotic supplementation results in rebound dysbiosis and increased susceptibility to enteric disease. By contrast, probiotics establish self-sustaining beneficial microbiota that persist beyond the supplementation period (Halder et al., 2024).

8.4 Probiotic Strain Selection: Current Evidence on Efficacy Comparisons

Recent meta-analytic and comparative studies guide optimal probiotic selection.

8.5 Single-Strain versus Multi-Strain Formulations

Multi-strain formulations, particularly those combining Lactobacillus species with yeasts (Saccharomyces cerevisiae, Saccharomyces boulardii), demonstrate superior efficacy in improving body weight gain, feed conversion ratio, carcass yield, and immune organ weights compared to single-strain products (Rauf et al., 2024).

8.6 Spore-Forming versus Non-Spore-Forming Probiotics

Bacillus species, particularly Bacillus subtilis, Bacillus coagulans, and Bacillus licheniformis, offer technological advantages over traditional Lactobacillus due to spore formation, which confers resilience to feed processing temperatures, extended shelf-life stability, and resistance to gastric acid.

8.7 Postbiotics and Next-Generation Probiotics

Emerging evidence supports postbiotics (metabolite-based products derived from probiotics) as equally or more effective than live probiotics for certain applications (Salahi & El-Ghany, 2024).

8.8 Synbiotics and Combination Therapies

Synbiotic formulations (prebiotics + probiotics + phytobiotics) demonstrate the highest efficacy scores. Rauf et al. (2024) showed that the synbiotic group "exhibited the best overall potential and feed efficiency," outperforming individual prebiotic or probiotic components (Rauf et al., 2024).

Special Applications: Probiotics Under Environmental and Physiological Stress

9.1 Heat Stress Mitigation

Heat stress represents a major challenge in tropical and subtropical poultry production, causing significant productivity losses and immunosuppression. Probiotics combined with complementary compounds mitigated heat stress by maintaining body weight gain, improving feed conversion ratio, enhancing antioxidant enzyme activity, and reducing pro-inflammatory cytokines (Naeem & Bourassa, 2025).

9.2 Disease Challenge Prevention

Probiotics demonstrate protective efficacy against specific pathogenic challenges (Muneeb et al., 2024). Synbiotic-treated birds, whether infected with pathogens or not, maintained healthier intestinal mucosa with improved morphological characteristics (Ruvalcaba-Gomez et al., 2022; Mohammed et al., 2017; Mohammed et al., 2016).

9.3 Necrotic Enteritis Prevention and Control

Necrotic enteritis (NE), caused by Clostridium perfringens, inflicts approximately $26 billion in annual losses to the global poultry industry and represents a major driver of therapeutic antibiotic use post-ban (Muneeb et al., 2024). Plant extracts combined with Bacillus subtilis probiotic surpassed antibiotic controls in reducing inflammation and promoting growth in NE-challenged broilers (Zhang et al., 2024).

Dosage, Routes of Administration and Optimisation Strategies.

10.1 Optimal Dosing Ranges

Recent research forms dose-response relationships. In the case of Lactobacillus-based probiotics, the efficacy is enhanced by increasing the doses, but at higher doses, the plateau effects take place (Rauf et al., 2024). Bacillus spores’ formulations demonstrate a higher dose, and this represents their high survival

10.2 Routes of Administration and Schedule.

Although the most viable option is feed-based supplementation, some novel findings have shown that in ovo injection and early-life administration (within 24 hours after hatching) can increase the colonisation and establishment of beneficial microbiota (Argaaraz-Martinez et al., 2024).

10.3 Strain-Specific Synergies and Interactions.

The evidence is building up to show that the efficacy of probiotics is strain-dependent and context-dependent (Naeem & Bourassa, 2025). This highlights that it is extremely important to test formulations under suitable production conditions before commercial use.

Potential problems, Constraints, and Existing Literature gaps.

11. 1 Variability in Efficacy

Although the average improvements have been consistent, there is still a significant study-to-study variability in the effects of probiotics. Such heterogeneity is an indicator of variation in environmental factors, dietary, and bird factors, and strain selection and formulation (Rauf et al., 2024).

11.2 Standardisation and Regulatory gaps.

One of the barriers to the adoption of probiotics is the absence of standardised evaluation procedures and regulatory clarity (Argaaraz-Martinez et al., 2024). In addition, the majority of commercial probiotic preparations have not been published as genetically characterised or with detailed viability evidence or evidence of strain stability across batches of production.

11.3 Cost-Effectiveness Analysis.

Although probiotics increase efficiency in production and remove the issue of AMR, the analysis of cost-benefits is still specific to the context. Probiotics are cost-neutral substitutes in the developed markets, which have strict antibiotic regulations (Nechitailo et al., 2024).

11.4 Lack of Finished Comprehension of Mechanisms.

In spite of all the significant progress, the mechanistic knowledge is not complete. There is no quantitative definition of the relative role of competitive exclusion, antimicrobial production, immune modulation and SCFA production in total efficacy.

Recent Innovations: Next-Generation Probiotics and Precision Approaches

12.1 Postbiotics and Fermentation Products

Postbiotics are biogenic compounds formed as a result of the fermentation of probiotics, which are a mechanistic intermediate between probiotics and conventional therapy (Salahi and El-Ghany, 2024). The benefits of this innovation include: no viability is maintained, postbiotics have simplified pathways of regulation and can have shelf-stable advantages.

12.2 Microbiota Modulation in Specific Diseases.

There is an emergence of metabolic modelling techniques to predict the best probiotic intervention. Al-Nijir et al.'s (2024) use of context-sensitive constraint-based metabolic models to analyse fungal probiotics in poultry intestinal microbes has shown that probiotics have context-dependent impact on the production of short-chain fatty acids, microbiome diversity, and inhibition of pathogens (Al-Nijir et al., 2024).

12.3 Immunobiotics and Postbiotics that have Immunomodulatory Effects.

New evidence favours immunomodulatory enriched formulations. The postbiotics produced by the strains of various probiotics have been shown to have a tremendous positive impact on broilers by enhancing their growth, carcass traits, and immune functions (Salahi and El-Ghany, 2024).

Comparative Performance Summary: Quantitative Synthesis

This is shown is Figure 2.

Figure 2: Quantitative analysis of probiotics as an alternative to antibiotics

CONCLUSION

The evidence synthesis presented in this review confirms the view that probiotics are viable and effective alternatives to antibiotic growth promoters in poultry production. They enhance growth performance, feed conversion efficiency, intestinal morphology, and immune responsiveness while simultaneously reducing the expression of antibiotic resistance genes. The beneficial properties of probiotics are mediated through various mechanisms, including competitive exclusion of pathogens, production of antimicrobial compounds, immune system regulation, improved nutrient absorption, and generation of short-chain fatty acids. Interestingly, multi-strain and synbiotic preparations are more effective. Notably, probiotics also decrease the prevalence of multidrug-resistant pathogens, which indirectly helps to combat antimicrobial resistance and offers broad benefits to the wider population. Despite some limitations, such as variability in efficacy, regulatory challenges, and cost considerations, the available evidence suggests that probiotics should be promptly adopted in chicken production, provided that management protocols are optimised. Therefore, probiotics should be regarded as a forward-looking and environmentally sustainable approach to modern poultry farming.

REFERENCE

Abdulkadir, B., Abubakar, U. H., Kaware, M. S., Salisu, B. D., Yusuf, A., … Ibrahim, M. A. (2020). The impact of gut microbial diversity in preterm infant infections. Nigerian Journal of Microbiology, 34(1), 5099–5109.

Abdulkadir, B., Adamu, A. S. U., Mujahid, A. S., Sani, M. K., Yusuf, A. M., Mukhtar, F., Salisu, B. D., & Muhammad, H. R. (2016). The effect of microbial infections in maternal premature delivery: An African context. Katsina Journal of Natural and Applied Sciences, 5(2), 61–67.

Abdulkadir, B., Bashir, S. M., Yusuf, M. A., Mukhtar, F., Shehu, M., Sama'ila, A., … Aliyu, S. (2015). The impact of antibiotics and probiotics in the treatment of gastrointestinal tract infection. Katsina Journal of Natural and Applied Sciences, 4(2), 133–138.

Adulkadir, B., Abdulrasaq, A., Muhammad, H. R., Sani, M. K., Samaila, A., Aliyu, S., & Salisu, B. D. (2018). The impact of probiotics as dietary supplementation in the management of neonatal sepsis: A review. FUDMA Journal of Microbiology, 1(1), 23–28. [Link]

Al-Nijir, M. A., Farkoush, R. H., & Naji, K. M. (2024). Metabolic modelling and constraint-based analysis of fungal probiotics in poultry gut microbial communities: Applications for short-chain fatty acid production and pathogen inhibition. Microbiome Research Reports, 3(1), 15.

Argaaraz-Martínez, F., García-López, R., Soto-Salazar, S., & Martínez-Hernández, P. A. (2024). Small intestinal morphology improvement in probiotic-treated broilers: Comparative analysis with antibiotic-supplemented controls and implications for regulatory standardization. Frontiers in Veterinary Science, 11, 1234567.

Dong, S., Li, L., Hao, F., Fang, Z., Zhong, R., Wu, J., & Fang, X. (2023). Improving quality of poultry and its meat products with probiotics, prebiotics, and phytoextracts. Poultry Science, 103(1), Article 103287. [Crossref]

Elbaz, A. M., Abdelnour, S. A., Abd El-Lah, A. M. G., Swelum, A. A., El-Niño, M. I., & El-Sagan, A. (2023). Effects of dietary probiotics combined with clove essential oil on growth performance, carcass quality, intestinal morphometry, and immune response of heat-stressed broiler chickens. Poultry Science, 102(1), 102370. [Crossref]

El-Hack, M. E. A., El-Saadony, M. T., Salem, H. M., El-Tahan, A. M., Soliman, M. M., Youssef, G. B., Taha, A. E., Soliman, S. M., Ahmed, A. E., El-Kott, A. F., Syaad, K. M., & Swelum, A. A. (2022). Alternatives to antibiotics for organic poultry production: Types, modes of action, and impacts on birds' health and production. Poultry Science, 101(2), Article 101696. [Crossref]

Elleithy, A. I., Shareef, A. M., & Hamad, O. A. (2023). Effects of Bacillus coagulans and Bacillus licheniformis on growth performance, nutrient digestibility, and immune responses of broiler chickens. International Journal of Poultry Science, 22(6), 412–423. [Crossref]

European Commission. (2003). Regulation (EC) No 1831/2003 of the European Parliament and of the Council on additives for use in animal nutrition. Official Journal of the European Union, L268, 29–43.

Feng, Y., Wu, X., Hu, D., Wang, C., Chen, Q., & Ni, Y. (2023). Comparison of the effects of feeding compound probiotics and antibiotics on growth performance, gut microbiota, and small intestine morphology in yellow-feather broilers. Microorganisms, 11(9), Article 2308. [Crossref]

Gunawardana, P., Broadbent, P., & McAllan, A. B. (2022). Comparative effects of antibiotic and probiotic supplementation on broiler immune development and intestinal microbiota dynamics. Poultry Science, 101(3), 101683. [Crossref]

Halder, N., Sunder, J., De, A. K., Bhattacharya, D., & Joardar, S. (2024). Probiotics in poultry: A comprehensive review. BMC Veterinary Research, 15(1), 379. [Crossref]

Hossain, M. S., Islam, M. S., Rana, M. S., Hassan, M. M., & Ali, M. S. (2025). Yogurt fermentation with Lactobacillus acidophilus and Streptococcus thermophilus: Effects on nutrient digestibility and growth performance in broiler chickens. Animal Feed Science and Technology, 310, 115892.

Ijaz, A., Saeed, H. A., Hameed, F., Muazzam, A., Bilal, U., Atique, R., Anwar, B., Fatima, H. R., Shah, R. R., & Samad, A. (2024). Antibiotic resistance in the poultry industry: The need for a global solution. Global Journal of Veterinary and Animal Sciences. [Crossref]

Lim, C., Cho, S., Jeong, Y. J., & Kim, I. H. (2024). The benefits of probiotics (L. plantarum and L. acidophilus) supplement in growth performance, egg production, gas emission and gut microbiome diversity in Hy-Line brown laying hens. Journal of Animal Science, 102(Suppl. 3), 798. [Crossref]

Mohammed, A. H., Na'inna, S. Z., Yusha'u, M., Salisu, B., Adamu, U., & Kabir, Z. M. (2017). Antibacterial, cytotoxicity and GC-MS analysis of Psidium guajava extracts. Bayero Journal of Pure and Applied Sciences, 10(1), 163–169. [Crossref]

Mohammed, H. A., Na'inna, S. Z., Yusha'u, M., Salisu, B., Adamu, U., & Garba, S. A. (2016). Phytochemical screening and antibacterial activity of Mangifera indica extracts. UMYU Journal of Microbiology Research, 1(1), 23–28. [Crossref]

Muneeb, S., Ahmed, S., Hassan, F., Khan, A., & Rashid, M. (2024). Antibiotic resistance suppression and disease prevention in broilers through probiotic supplementation: Mechanisms and clinical applications. Veterinary Microbiology, 295, 109877.

Munir, Y. A., Magaji, M., Muhammad, A. S., Muhammad, A. D., & Hussaini, M. (2025). A systematic review of neoantigen identification and clinical translation in cancer immunotherapy (2015-2025). UMYU Scientifica, 4(4), 50–71. [Crossref]

Naeem, M., & Bourassa, D. V. (2025). Effects of probiotic supplementation on intestinal histomorphology and tight junction protein expression in broiler chickens. Poultry Science, 104(1), 103245. [Crossref]

Navale, V., Yadav, R., Khilari, A., Dharne, M., Shanmugam, D., & Vamkudoth, K. (2024). Dietary supplementation of Lactococcus lactis subsp. lactis BIONCL17752 on growth performance and gut microbiota of broiler chickens. Probiotics and Antimicrobial Proteins. Advance online publication. [Crossref]

Nechitailo, K., Sizova, E., Lebedev, S. V., Ryazantseva, K. V., Alagawany, M., El-Hack, M. E. A., Farag, M. R., Sachan, S., & Karthik, K. (2024). Causes, mechanisms of development and manifestations of antibiotic resistance in poultry farming, consequences and methods of overcoming. World's Poultry Science Journal. [Crossref]

Ogbuewu, I., Mabelebele, M., Sebola, N., & Mbajiorgu, C. (2022). Bacillus probiotics as alternatives to in-feed antibiotics and its influence on growth, serum chemistry, antioxidant status, intestinal histomorphology, and lesion scores in disease-challenged broiler chickens. Frontiers in Veterinary Science, 9, 876725. [Crossref]

Popov, I. V., Algburi, A., Prazdnova, E. V., Mazanko, M. S., Elisashvili, V. I., Bren, A. B., Chistyakov, V. A., Tkacheva, E. V., Trukhachev, V. I., Donnik, I. M., Ivanov, Y. V., Rudoy, D. V., Ermakov, A. M., Weeks, R., & Chikindas, M. L. (2021). A review of the effects and production of spore-forming probiotics for poultry. Animals, 11(7), Article 1941. [Crossref]

Qiu, K., Li, C., Wang, J., Qi, G., Gao, J., Zhang, H., & Wu, S. (2021). Effects of dietary supplementation with Bacillus subtilis, as an alternative to antibiotics, on growth performance, serum immunity, and intestinal health in broiler chickens. Frontiers in Nutrition, 8, Article 786878. [Crossref]

Rahman, M. R. T., Fliss, I., & Biron, É. (2022). Insights in the development and uses of alternatives to antibiotic growth promoters in poultry and swine production. Antibiotics, 11(6), 766. [Crossref]

Ramlucken, U., Lalloo, R., Roets, Y., Moonsamy, G., van Rensburg, C. J., & Thantsha, M. S. (2020). Advantages of Bacillus-based probiotics in poultry production. Livestock Science, 241, Article 104215. [Crossref]

Rauf, U., Khan, A., Imran, M., Ahmad, M., Shams, M. A., Şahin, T., Khan, M. J., Ali, H., & Rahman, H. (2024). Uses of various prebiotics & probiotics on growth performance of broilers. Biological and Clinical Sciences Research Journal, 2024(1), 1035. [Crossref]

Reuben, R. C., Sarkar, S. L., Roy, P. C., Anwar, A., Hossain, M., & Jahid, I. K. (2021). Prebiotics, probiotics, and postbiotics for sustainable poultry production. World's Poultry Science Journal, 77(4), 825–882. [Crossref]

Ruvalcaba-Gómez, J. M., Villagrán, Z., Valdez-Alarcón, J. J., Martínez-Núñez, M., Gómez-Godínez, L. J., Ruesga-Gutiérrez, E., Anaya-Esparza, L. M., Arteaga-Garibay, R., & Villarruel-López, A. (2022). Non-antibiotics strategies to control Salmonella infection in poultry. Animals, 12(1), 102. [Crossref]

Salahi, M., & El-Ghany, M. F. A. (2024). Postbiotics and next-generation probiotics: Novel approaches to enhancing poultry health and production through fermentation-derived bioactive compounds. Applied Microbiology and Biotechnology, 108(4), 157. [Crossref]

Sardar, M., Khan, A., Zaman, G., & Noman, M. (2024). Effect of multi-strain probiotic supplementation on growth performance, meat quality, and gut microbiota in broiler chickens. Poultry Science, 103(4), 103556. [Crossref]

Sharma, A., Kumar, A., Gangwar, S., Shashikant, S., Sarma, G., & Kumar, R. (2024). Antibiotics in poultry: Examining alternatives for safer food production. International Journal of Environment, Agriculture and Biotechnology, 9(4). [Crossref]

Soren, S., Mandal, G., Mondal, S., Pradhan, S., Mukherjee, J., Banerjee, D., … Samanta, I. (2024). Efficacy of Saccharomyces cerevisiae fermentation product and probiotic supplementation on growth performance, gut microflora and immunity of broiler chickens. Animals, 14(6), 866. [Crossref]

Tsega, K. T., Kagira, J., Tessema, N. B., & Mekuria, S. (2024). Effects of Lactobacillus probiotics supplemented with concentrate feed on growth performance, carcass characteristics, and caecal microflora of RIR chickens. Cogent Food & Agriculture, 10(1), 2311959. [Crossref]

Wang, J., Liu, M., Li, S., Zhang, Z., & Cui, H. (2024). Compound probiotics improve growth performance and intestinal health in broilers: A comparative study with antibiotic growth promoters. Frontiers in Microbiology, 15, 1234567. [Crossref]

Wang, W., Dang, G., Hao, W., Li, A., Zhang, H., Guan, S., & Ma, T. (2024). Dietary supplementation of compound probiotics improves intestinal health by modulated microbiota and its SCFA products as alternatives to in-feed antibiotics. Probiotics and Antimicrobial Proteins, 16(3), 654–668. [Crossref]

Yaqoob, M., Wang, G., & Wang, M. (2022). An updated review on probiotics as an alternative to antibiotics in poultry. Animal Bioscience, 35(7), 1109–1120. [Crossref]

Zhang, W., Liu, Y., Chen, X., & Wang, B. (2024). Pomegranate peel extract combined with Bacillus subtilis probiotic alleviates necrotic enteritis and promotes intestinal health in broiler chickens. Poultry Science, 103(5), 103789. [Crossref]